<p><b>A:</b> HeLa cells were treated with various concentrations of TSA for 12, 24, or 48<b>B:</b> HeLa cells were treated with 1,000 nM CytoD for 6, 12, or 18 h. <b>C:</b> HeLa cells were treated with 500 nM LatB for 3, 6, or 12 h. <b>D:</b> HeLa cells were treated for 24 h with various concentrations of TSA in the presence or absence of 500 nM LatB or 1,000 nM CytoD. Cells were fixed with 40% ethanol and stained with PI, and then hypodiploid cells were analyzed by flow cytometry. <b>E–F:</b> HeLa cells were treated for 16 h with 1,000 nM TSA in the presence or absence of 500 nM LatB or 1,000 nM CytoD. Cells were stained with annexin V-FITC and PI, and then analyzed by flow cytometry (E). Cells were fixed with 3% paraformaldehyde and stain...
<p>(a) Representative DNA histograms of cells following treatment with indicated concentrations of C...
<p><b>A</b>, HeLa/TSA cells were analyzed for UbB, UbC, UbA52 and UbA80 mRNA levels. The columns rep...
<p>The expanded human cord blood-derived CD34<sup>+</sup> cells (Day 0) were treated with LT on day ...
<p>Hypodiploid cell formation was increased by incubation with TSA, CytoD, or LatB. <b>A–C:</b> HeLa...
<p><b>A–B:</b> HeLa cells were treated for 3(•) in the presence or absence of 1,000 nM CytoD (□) or ...
<p><b>A</b>, HeLa cells were treated with 500 nM TSA for the indicated times and subjected to analys...
<p>Cell cycle analysis of RPE cells treated with 0–1 μM TSA for 24 h, fixed with ice-cold 70% ethano...
<p>(<b>A</b>) Histograms depict cell cycle distributions in MCF-10A, MDA-MB-231 and MCF-7 cells afte...
<p>Human cord blood-derived CD34<sup>+</sup> cells were treated using LT and rLT on Day 12 and analy...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
<p>A and B) Tax-inducible cell line JPX9 and Jurkat control cells were induced with CdCl, γ-irradiat...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p><b>A</b>, Wound healing assay was performed in 48 hour-treated hESCs at two different TSA concent...
<p><i>A</i>, TcdB does not induce caspase-3/7 activation in HeLa cells, as detected by a fluorescent...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>(a) Representative DNA histograms of cells following treatment with indicated concentrations of C...
<p><b>A</b>, HeLa/TSA cells were analyzed for UbB, UbC, UbA52 and UbA80 mRNA levels. The columns rep...
<p>The expanded human cord blood-derived CD34<sup>+</sup> cells (Day 0) were treated with LT on day ...
<p>Hypodiploid cell formation was increased by incubation with TSA, CytoD, or LatB. <b>A–C:</b> HeLa...
<p><b>A–B:</b> HeLa cells were treated for 3(•) in the presence or absence of 1,000 nM CytoD (□) or ...
<p><b>A</b>, HeLa cells were treated with 500 nM TSA for the indicated times and subjected to analys...
<p>Cell cycle analysis of RPE cells treated with 0–1 μM TSA for 24 h, fixed with ice-cold 70% ethano...
<p>(<b>A</b>) Histograms depict cell cycle distributions in MCF-10A, MDA-MB-231 and MCF-7 cells afte...
<p>Human cord blood-derived CD34<sup>+</sup> cells were treated using LT and rLT on Day 12 and analy...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
<p>A and B) Tax-inducible cell line JPX9 and Jurkat control cells were induced with CdCl, γ-irradiat...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p><b>A</b>, Wound healing assay was performed in 48 hour-treated hESCs at two different TSA concent...
<p><i>A</i>, TcdB does not induce caspase-3/7 activation in HeLa cells, as detected by a fluorescent...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>(a) Representative DNA histograms of cells following treatment with indicated concentrations of C...
<p><b>A</b>, HeLa/TSA cells were analyzed for UbB, UbC, UbA52 and UbA80 mRNA levels. The columns rep...
<p>The expanded human cord blood-derived CD34<sup>+</sup> cells (Day 0) were treated with LT on day ...